loading...

Brazil Cell & Gene Therapy Business and Investment Opportunities Databook

According to BioIntel360, Brazil’s cell and gene therapy market size is expected to record a CAGR of 6.7% during 2023-2027 to reach US$206.6 million by 2027, increasing from US$159.5 million in 2023....

Brazil Cell & Gene Therapy Business and Investment Opportunities Databook – Q1 2023 Update
Summary
According to BioIntel360, Brazil’s cell and gene therapy market size is expected to record a CAGR of 6.7% during 2023-2027 to reach US$206.6 million by 2027, increasing from US$159.5 million in 2023. Over the last five years, the sector has recorded a CAGR of 7.2% to reach US$149.2 million in 2022.

This report provides an in-depth data-centric analysis of the emerging opportunities in cell and gene therapy industry. It covers a detailed view of market size and forecast across various segments such as by different therapy segment, type of therapy, the purpose of manufacturing, type of cell, route of administration, delivery mode, source of cell,  source of manufacturing, therapeutic class, technology, end-user and by product.

This databook is a part of the title “Global Cell & Gene Therapy Business and Investment Opportunities – Analysis & Market Size by Technology, Clinical Trials, Patents, Financial Deals, Competitive Landscape – Q1 2023 Update”.

Scope
This report provides an in-depth, data-centric analysis of the Brazil cell and gene therapy market 2018-2027. Below is a summary of key market segments:

Cell & Gene Therapy Market Size by Different Therapy Segment, 2018-2027
• Cell and Gene Modified Cell Therapies
• Gene Therapy and Genome Therapy
• DNA & RNA Therapeutics

Cell & Gene Therapy Market Size by Purpose of Manufacturing
• Commercial
• Clinical

Cell & Gene Therapy Market Size by Product
• Abecma
• Amondys
• Breyanzi
• Carvykti
• Givlaari
• Kimmtrak
• Kymriah
• Leqvio
• Luxturna
• Onpattro
• Oxlumo
• Rethymic
• Skysona
• Stratagraft
• Tecartus
• Tegsedi
• Viltepso
• Vyondys
• Yescarta
• Zolgensma
• Zynteglo

Cell & Gene Therapy Market Size by Route of Administration
• Injectables
• Infusions
• Bioscaffolds
• Topicals

Cell & Gene Therapy Market Size by Type of Cell
• CAR-T Cell
• TCR Cell

Cell & Gene Therapy Market Size by Type of Therapy
• T-Cell Therapies
• NK Cell
• Dendritic Cell Therapies
• Stem Cell Therapies

Cell & Gene Therapy Market Size by Source of Cell
• Autologous
• Allogenic

Cell & Gene Therapy Market Size by Delivery Mode
• In vivo
• ex-vivo

Cell & Gene Therapy Market Size by Source of Manufacturing
• In-House
• Contract Manufacturing

Cell & Gene Therapy Market Size by Therapeutic Class
• Oncology
• Neurology
• Ophthalmology
• Musculoskeletal
• Others

Cell & Gene Therapy Market Size by Technology
• Viral Vector Technology
• Cell Immortalization Technology
• Genome Editing Technology
• Others

Cell & Gene Therapy Market Size by End User
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Hospital & Clinics
Reason to buy
• In-depth understanding of cell and gene therapy market dynamics: Understand market opportunity, industry dynamics, key trends and drivers across different market segments and sub-segments of the industry in Brazil.

• Develop market-specific strategies: Identify growth segments and target specific opportunities to formulate your investment strategy; assess market-specific key trends, drivers, and risks in the industry.

• Get market share analysis by end users: Get a detailed analysis across different end users such as pharmaceutical, biotechnology companies, academic & research institutes, and by hospitals & clinics within the Brazil.


Table of Contents
 1 Brazil Cell and Gene Therapy Market Size and Forecast, 2018-2027

2 Brazil Cell and Gene Therapy Market Share by Different Therapy Segment, 2018-2027
2.1 Brazil Market Size by Cell and Gene Modified Cell Therapies, 2018-2027
2.2 Brazil Market Size by Gene Therapy and Genome Therapy, 2018-2027
2.3 Brazil Cell and Gene Therapy Market Size by DNA & RNA Therapeutics, 2018-2027

3 Brazil Cell and Gene Therapy Market Share by Purpose of Manufacturing, 2018-2027
3.1 Brazil Cell and Gene Therapy Market Size by Commercial, 2018-2027
3.2 Brazil Cell and Gene Therapy Market Size by Clinical, 2018-2027

4 Brazil Cell and Gene Therapy Market Share by Product, 2018-2027

5 Brazil Cell and Gene Therapy Market Share by Route of Administration, 2018-2027
5.1 Brazil Cell and Gene Therapy Market Size by Injectables, 2018-2027
5.2 Brazil Cell and Gene Therapy Market Size by Topicals, 2018-2027
5.3 Brazil Cell and Gene Therapy Market Size by Infusions, 2018-2027
5.4 Brazil Cell and Gene Therapy Market Size by Bioscaffolds, 2018-2027

6 Brazil Cell and Gene Therapy Market Share by Type of Diseases, 2018-2027
6.1 Brazil Cell and Gene Therapy Market Size by Rare Diseases, 2018-2027
6.2 Brazil Cell and Gene Therapy Market Size by Non-Rare Diseases, 2018-2027

7 Brazil Cell and Gene Therapy Market Share by Type of Cell, 2018-2027
7.1 Brazil Cell and Gene Therapy Market Size by CAR-T Cell, 2018-2027
7.2 Brazil Cell and Gene Therapy Market Size by TCR Cell, 2018-2027

8 Brazil Cell and Gene Therapy Market Share by Therapy, 2018-2027
8.1 Brazil Cell and Gene Therapy Market Size by T-Cell Therapies, 2018-2027
8.2 Brazil Cell and Gene Therapy Market Size by NK Cell, 2018-2027
8.3 Brazil Cell and Gene Therapy Market Size by Dendritic Cell Therapies, 2018-2027
8.4 Brazil Cell and Gene Therapy Market Size by Stem Cell Therapies, 2018-2027

9 Brazil Cell and Gene Therapy Market Share by Source of Cell, 2018-2027
9.1 Brazil Cell and Gene Therapy Market Size by Autologous, 2018-2027
9.2 Brazil Cell and Gene Therapy Market Size by Allogenic, 2018-2027

10 Brazil Cell and Gene Therapy Market Share by Delivery Mode, 2018-2027
10.1 Brazil Cell and Gene Therapy Market Size by In-vivo, 2018-2027
10.2 Brazil Cell and Gene Therapy Market Size by Ex-vivo, 2018-2027

11 Brazil Cell and Gene Therapy Market Share by Source of Manufacturing, 2018-2027
11.1 Brazil Cell and Gene Therapy Market Size by In-House, 2018-2027
11.2 Brazil Cell and Gene Therapy Market Size by Contract Manufacturing, 2018-2027

12 Brazil Cell and Gene Therapy Market Share by Therapeutic Class, 2018-2027
12.1 Brazil Cell and Gene Therapy Market Size by Oncology, 2018-2027
12.2 Brazil Cell and Gene Therapy Market Size by Neurology, 2018-2027
12.3 Brazil Cell and Gene Therapy Market Size by Ophthalmology, 2018-2027
12.4 Brazil Cell and Gene Therapy Market Size by Musculoskeletal, 2018-2027
12.5 Brazil Cell and Gene Therapy Market Size by Others, 2018-2027

13 Brazil Cell and Gene Therapy Market Share by Technology, 2018-2027
13.1 Brazil Cell and Gene Therapy Market Size by Viral Vector Technology, 2018-2027
13.2 Brazil Cell and Gene Therapy Market Size by Cell Immortalization Technology, 2018-2027
13.3 Brazil Cell and Gene Therapy Market Size by Genome Editing Technology, 2018-2027
13.4 Brazil Cell and Gene Therapy Market Size by Others Technologies, 2018-2027

14 Brazil Cell and Gene Therapy Market Share by End User, 2018-2027
14.1 Brazil Cell and Gene Therapy Market Size by Pharmaceutical & Biotechnology Companies, 2018-2027
14.2 Brazil Cell and Gene Therapy Market Size by Academic & Research Institutes, 2018-2027
14.3 Brazil Cell and Gene Therapy Market Size by Hospital & Clinics, 2018-2027
List Of Table
Table 1: Brazil Cell and Gene Therapy Market Size by Value (USD MM) 2018-2027
Table 2: Brazil Cell and Gene Therapy Market Size by Cell and Gene Modified Cell Therapies, by Value (USD MM), 2018-2027
Table 3: Brazil Cell and Gene Therapy Market Size by Gene Therapy and Genome Therapy, by Value (USD MM) 2018-2027
Table 4: Brazil Cell and Gene Therapy Market Size by DNA & RNA Therapeutics, by Value (USD MM) 2018-2027
Table 5: Brazil Cell and Gene Therapy Market Size by Commercial, by Value (USD MM) 2018-2027
Table 6: Brazil Cell and Gene Therapy Market Size by Clinical, by Value (USD MM) 2018-2027
Table 7: Brazil Cell and Gene Therapy Market Size by Injectables, by Value (USD MM) 2018-2027
Table 8: Brazil Cell and Gene Therapy Market Size by Topicals, by Value (USD MM) 2018-2027
Table 9: Brazil Cell and Gene Therapy Market Size by Infusions, by Value (USD MM) 2018-2027
Table 10: Brazil Cell and Gene Therapy Market Size by Bio scaffolds, by Value (USD MM) 2018-2027
Table 11: Brazil Cell and Gene Therapy Market Size by Rare Diseases, by Value (UDS MM) 2018-2027
Table 12: Brazil Cell and Gene Therapy Market Size by Non-Rare Diseases, by Value (UDS MM) 2018-2027
Table 13: Brazil Cell and Gene Therapy Market Size by CAR-T Cell, by Value (UDS MM) 2018-2027
Table 14: Brazil Cell and Gene Therapy Market Size by TCR Cell, by Value (UDS MM) 2018-2027
Table 15: Brazil Cell and Gene Therapy Market Size by T-Cell Therapies, by Value (USD MM), 2018-2027
Table 16: Brazil Cell and Gene Therapy Market Size by NK Cell, by Value (USD MM), 2018-2027
Table 17: Brazil Cell and Gene Therapy Market Size by Dendritic Cell Therapies, by Value (USD MM), 2018-2027
Table 18: Brazil Cell and Gene Therapy Market Size by Stem Cell Therapies, by Value (USD MM), 2018-2027
Table 19: Brazil Cell and Gene Therapy Market Size by Autologous (USD MM), 2018-2027
Table 20: Brazil Cell and Gene Therapy Market Size by Allogenic (USD MM), 2018-2027
Table 21: Brazil Cell and Gene Therapy Market Size by In-vivo, by Value (USD MM), 2018-2027
Table 22: Brazil Cell and Gene Therapy Market Size by Ex-vivo, by Value (USD MM), 2018-2027
Table 23: Brazil Cell and Gene Therapy Market Size by In-House, by Value (USD MM), 2018-2027
Table 24: Brazil Cell and Gene Therapy Market Size by Contract Manufacturing, by Value (USD MM), 2018-2027
Table 25: Brazil Cell and Gene Therapy Market Size by Oncology, by Value (USD MM), 2018-2027
Table 26: Brazil Cell and Gene Therapy Market Size by Neurology, by Value (USD MM), 2018-2027
Table 27: Brazil Cell and Gene Therapy Market Size by Ophthalmology, by Value (USD MM), 2018-2027
Table 28: Brazil Cell and Gene Therapy Market Size by Musculoskeletal, by Value (USD MM), 2018-2027
Table 29: Brazil Cell and Gene Therapy Market Size by Others, by Value (USD MM), 2018-2027
Table 30: Brazil Cell and Gene Therapy Market Size by Viral Vector Technology, by Value (USD MM), 2018-2027
Table 31: Brazil Cell and Gene Therapy Market Size by Cell Immortalization Technology, by Value (USD MM), 2018-2027
Table 32: Brazil Cell and Gene Therapy Market Size by Genome Editing Technology, by Value (USD MM), 2018-2027
Table 33: Brazil Cell and Gene Therapy Market Size by Others Technologies, by Value (USD MM), 2018-2027
Table 34: Brazil Cell and Gene Therapy Market Size by Pharmaceutical & Biotechnology Companies, by Value (USD MM), 2018-2027
Table 35: Brazil Cell and Gene Therapy Market Size by Academic & Research Institutes, by Value (USD MM), 2018-2027
Table 36: Brazil Cell and Gene Therapy Market Size by Hospital & Clinics, by Value (USD MM), 2018-2027
List of figures
Figure 1: Brazil Cell and Gene Therapy Market Size by Value (USD MM) 2018-2027
Figure 2: Brazil Cell and Gene Therapy Market Share by Different Therapy Segment (%), 2018-2027
Figure 3: Brazil Cell and Gene Therapy Market Size by Cell and Gene Modified Cell Therapies, by Value (USD MM), 2018-2027
Figure 4: Brazil Cell and Gene Therapy Market Size by Gene Therapy and Genome Therapy, by Value (USD MM) 2018-2027
Figure 5: Brazil Cell and Gene Therapy Market Size by DNA & RNA Therapeutics, by Value (USD MM) 2018-2027
Figure 6: Brazil Cell and Gene Therapy Market Share Purpose of Manufacturing (%), 2018-2027
Figure 7: Brazil Cell and Gene Therapy Market Size by Commercial, by Value (USD MM) 2018-2027
Figure 8: Brazil Cell and Gene Therapy Market Size, By Clinical, by Value (USD MM) 2018-2027
Figure 9: Brazil Cell and Gene Therapy Market Share by Product (%), 2018-2027
Figure 10: Brazil Cell and Gene Therapy Market Share by Route of Administration (%), 2018-2027
Figure 11: Brazil Cell and Gene Therapy Market Size by Injectables, by Value (USD MM) 2018-2027
Figure 12: Brazil Cell and Gene Therapy Market Size by Topicals, by Value (USD MM) 2018-2027
Figure 13: Brazil Cell and Gene Therapy Market Size by Infusions, by Value (USD MM) 2018-2027
Figure 14: Brazil Cell and Gene Therapy Market Size by Bio scaffolds, by Value (USD MM) 2018-2027
Figure 15: Brazil Cell and Gene Therapy Market Share by Type of Diseases (%), 2018-2027
Figure 16: Brazil Cell and Gene Therapy Market Share by Rare Diseases, by Value (UDS MM) 2018-2027
Figure 17: Brazil Cell and Gene Therapy Market Share by Non-Rare Diseases, by Value (UDS MM) 2018-2027
Figure 18: Brazil Cell and Gene Therapy Market Share by Type of Cell (%), 2018-2027
Figure 19: Brazil Cell and Gene Therapy Market Share by CAR-T Cell, by Value (UDS MM) 2018-2027
Figure 20: Brazil Cell and Gene Therapy Market Share by TCR Cell, by Value (UDS MM) 2018-2027
Figure 21: Brazil Cell and Gene Therapy Market Share by Therapy (%), 2018-2027
Figure 22: Brazil Cell and Gene Therapy Market Size by T-Cell Therapies, by Value (USD MM), 2018-2027
Figure 23: Brazil Cell and Gene Therapy Market Size by NK Cell, by Value (USD MM), 2018-2027
Figure 24: Brazil Cell and Gene Therapy Market Size by Dendritic Cell Therapies, by Value (USD MM), 2018-2027
Figure 25: Brazil Cell and Gene Therapy Market Size by Stem Cell Therapies, by Value (USD MM), 2018-2027
Figure 26: Brazil Cell and Gene Therapy Market Share by Source of Cell (%), 2018-2027
Figure 27: Brazil Cell and Gene Therapy Market Size by Autologous (USD MM), 2018-2027
Figure 28: Brazil Cell and Gene Therapy Market Size by Allogenic (USD MM), 2018-2027
Figure 29: Brazil Cell and Gene Therapy Market Share by Delivery Mode (%), 2018-2027
Figure 30: Brazil Cell and Gene Therapy Market Size by In-vivo, by Value (USD MM), 2018-2027
Figure 31: Brazil Cell and Gene Therapy Market Size by Ex-vivo, by Value (USD MM), 2018-2027
Figure 32: Brazil Cell and Gene Therapy Market Share by Source of Manufacturing (%), 2018-2027
Figure 33: Brazil Cell and Gene Therapy Market Size by In-House, by Value (USD MM), 2018-2027
Figure 34: Brazil Cell and Gene Therapy Market Size by Contract Manufacturing, by Value (USD MM), 2018-2027
Figure 35: Brazil Cell and Gene Therapy Market Share by Therapeutic Class (%), 2018-2027
Figure 36: Brazil Cell and Gene Therapy Market Size by Oncology, by Value (USD MM), 2018-2027
Figure 37: Brazil Cell and Gene Therapy Market Size by Neurology, by Value (USD MM), 2018-2027
Figure 38: Brazil Cell and Gene Therapy Market Size by Ophthalmology, by Value (USD MM), 2018-2027
Figure 39: Brazil Cell and Gene Therapy Market Size by Musculoskeletal, by Value (USD MM), 2018-2027
Figure 40: Brazil Cell and Gene Therapy Market Size by Others, by Value (USD MM), 2018-2027
Figure 41: Brazil Cell and Gene Therapy Market Share by Technology (%), 2018-2027
Figure 42: Brazil Cell and Gene Therapy Market Size by Viral Vector Technology, by Value (USD MM), 2018-2027
Figure 43: Brazil Cell and Gene Therapy Market Size by Cell Immortalization Technology, by Value (USD MM), 2018-2027
Figure 44: Brazil Cell and Gene Therapy Market Size by Genome Editing Technology, by Value (USD MM), 2018-2027
Figure 45: Brazil Cell and Gene Therapy Market Size by Others Technologies, by Value (USD MM), 2018-2027
Figure 46: Brazil Cell and Gene Therapy Market Share by End User (%), 2018-2027
Figure 47: Brazil Cell and Gene Therapy Market Size by Pharmaceutical & Biotechnology Companies, by Value (USD MM), 2018-2027
Figure 48: Brazil Cell and Gene Therapy Market Size by Academic & Research Institutes, by Value (USD MM), 2018-2027
Figure 49: Brazil Cell and Gene Therapy Market Size by Hospital & Clinics, by Value (USD MM), 2018-2027
Request a Report
Email This Page to a colleague
Recipient #1
Recipient #2
Recipient #3
Recipient #4
Recipient #5
BioIntel360